These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8944215)

  • 1. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran).
    Tincello DG; Johnstone MJ
    Postgrad Med J; 1996 Nov; 72(853):688-9. PubMed ID: 8944215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gabapentin on hyperemesis gravidarum: a double-blind, randomized controlled trial.
    Guttuso T; Messing S; Tu X; Mullin P; Shepherd R; Strittmatter C; Saha S; Thornburg LL
    Am J Obstet Gynecol MFM; 2021 Jan; 3(1):100273. PubMed ID: 33451591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron Use in Pregnancy.
    Siminerio LL; Bodnar LM; Venkataramanan R; Caritis SN
    Obstet Gynecol; 2016 May; 127(5):873-877. PubMed ID: 27054931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intractable hyperemesis gravidarum by ondansetron.
    Siu SS; Yip SK; Cheung CW; Lau TK
    Eur J Obstet Gynecol Reprod Biol; 2002 Oct; 105(1):73-4. PubMed ID: 12270570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of intravenous ondansetron for hyperemesis gravidarum.
    Sullivan CA; Johnson CA; Roach H; Martin RW; Stewart DK; Morrison JC
    Am J Obstet Gynecol; 1996 May; 174(5):1565-8. PubMed ID: 9065130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial.
    Abas MN; Tan PC; Azmi N; Omar SZ
    Obstet Gynecol; 2014 Jun; 123(6):1272-1279. PubMed ID: 24807340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaining Insight Into Ondansetron Safety in Early Pregnancy.
    Lavecchia M; Chari R; Ross S
    J Obstet Gynaecol Can; 2019 Apr; 41(4):419-420. PubMed ID: 30685231
    [No Abstract]   [Full Text] [Related]  

  • 8. Validating the effect of Ondansetron and Mirtazapine In Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial.
    Ostenfeld A; Petersen TS; Futtrup TB; Andersen JT; Jensen AK; Westergaard HB; Pedersen LH; Løkkegaard ECL
    BMJ Open; 2020 Mar; 10(3):e034712. PubMed ID: 32209630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States.
    Fejzo MS; MacGibbon KW; Mullin PM
    Reprod Toxicol; 2016 Jul; 62():87-91. PubMed ID: 27151373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study.
    Ditto A; Morgante G; la Marca A; De Leo V
    Gynecol Obstet Invest; 1999; 48(4):232-6. PubMed ID: 10592423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label use of ondansetron in pregnancy in Western Australia.
    Colvin L; Gill AW; Slack-Smith L; Stanley FJ; Bower C
    Biomed Res Int; 2013; 2013():909860. PubMed ID: 24396830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ondansetrone or metoclopromide? Which is more effective in severe nausea and vomiting of pregnancy? A randomized trial double-blind study.
    Kashifard M; Basirat Z; Kashifard M; Golsorkhtabar-Amiri M; Moghaddamnia A
    Clin Exp Obstet Gynecol; 2013; 40(1):127-30. PubMed ID: 23724526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for hyperemesis gravidarum.
    Abramowitz A; Miller ES; Wisner KL
    Arch Womens Ment Health; 2017 Jun; 20(3):363-372. PubMed ID: 28070660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
    Moussa G; Genest M; Villeneuve E; Wang JJ
    Ann Emerg Med; 2021 May; 77(5):555. PubMed ID: 33902836
    [No Abstract]   [Full Text] [Related]  

  • 15. Intestinal obstruction is a rare complication of ondansetron exposure in hyperemesis gravidarum.
    Fejzo MS; MacGibbon K; Mullin P
    Reprod Toxicol; 2015 Nov; 57():207. PubMed ID: 26196894
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.
    Boelig RC; Barton SJ; Saccone G; Kelly AJ; Edwards SJ; Berghella V
    J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2492-2505. PubMed ID: 28614956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
    Perez EA
    Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal obstruction in pregnancy by ondansetron.
    Cohen R; Shlomo M; Dil DN; Dinavitser N; Berkovitch M; Koren G
    Reprod Toxicol; 2014 Dec; 50():152-3. PubMed ID: 25461913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature.
    Guclu S; Gol M; Dogan E; Saygili U
    Arch Gynecol Obstet; 2005 Oct; 272(4):298-300. PubMed ID: 16007504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.